^
    9ms
    Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma (clinicaltrials.gov)
    P1, N=22, Active, not recruiting, Alpheus Medical, Inc. | Recruiting --> Active, not recruiting | N=48 --> 22 | Trial completion date: Dec 2024 --> Apr 2025 | Trial primary completion date: Dec 2023 --> Dec 2024
    Enrollment closed • Enrollment change • Trial completion date • Trial primary completion date
    |
    5-ALA with CV01
    over1year
    Study to Evaluate 5-ALA Combined With CV01 Delivery of Ultrasound in Recurrent High Grade Glioma (clinicaltrials.gov)
    P1, N=48, Recruiting, Alpheus Medical, Inc. | N=33 --> 48 | Trial completion date: Apr 2024 --> Dec 2024 | Trial primary completion date: Apr 2023 --> Dec 2023
    Enrollment change • Trial completion date • Trial primary completion date
    |
    5-ALA with CV01